Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Michael F. Gowen"'
Autor:
Ryan Fan, BA, Margaret S. Johnston, MD, Michael F. Gowen, MD, William Damsky, MD, PhD, Ian Odell, MD, PhD, James Clune, MD, Matthew D. Vesely, MD, PhD
Publikováno v:
JAAD Case Reports, Vol 27, Iss , Pp 61-63 (2022)
Externí odkaz:
https://doaj.org/article/ce48d672b28845e1a552763465be7c17
Autor:
Michael F. Gowen, Keith M. Giles, Danny Simpson, Jeremy Tchack, Hua Zhou, Una Moran, Zarmeena Dawood, Anna C. Pavlick, Shaohui Hu, Melissa A. Wilson, Hua Zhong, Michelle Krogsgaard, Tomas Kirchhoff, Iman Osman
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-12 (2018)
Abstract Background Immune checkpoint inhibitors (anti-CTLA-4, anti-PD-1, or the combination) enhance anti-tumor immune responses, yielding durable clinical benefit in several cancer types, including melanoma. However, a subset of patients experience
Externí odkaz:
https://doaj.org/article/25bad45d849a486cbdacef0da4e5f3a3
Autor:
Elena Sokolova, Sebastian Stefan, Iman Osman, Ana de Pablos-Aragoneses, Eleazar De Miera-Vega, Aristotelis Tsirigos, Yixiao Gong, Eva Hernando, Michael F. Gowen, Vanessa Ortiz-Barahona, Diana Argibay, Farbod Darvishian, Rana S. Moubarak, Igor Dolgalev, Richard Von Itter
Publikováno v:
Cancer Research. 80:B30-B30
The specific contribution of epigenetic dysregulation to the metastatic process remains understudied. Through a meta-analysis of gene expression datasets followed by a functional mini-screen, we identified PHF8, a histone demethylase of the Jumonji C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ae5f1d5ea69bc96710f16f3fcd3a87e
https://doi.org/10.1158/1538-7445.mel2019-b30
https://doi.org/10.1158/1538-7445.mel2019-b30
Autor:
Michelle Krogsgaard, Una Moran, Shaohui Hu, Keith M. Giles, Melissa Wilson, Hua Zhong, Jeremy Tchack, Danny Simpson, Hua Zhou, Michael F. Gowen, Tomas Kirchhoff, Zarmeena Dawood, Iman Osman, Anna C. Pavlick
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-12 (2018)
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-12 (2018)
Background Immune checkpoint inhibitors (anti-CTLA-4, anti-PD-1, or the combination) enhance anti-tumor immune responses, yielding durable clinical benefit in several cancer types, including melanoma. However, a subset of patients experience immune-r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b84c82a72260e3cdad618673e3c3653
https://pubmed.ncbi.nlm.nih.gov/29606147
https://pubmed.ncbi.nlm.nih.gov/29606147
Autor:
Andrea Tuccoli, Gao Zhang, Chiara Ippolito, Omotayo Ope, Marco Pellegrini, Laura Comelli, Laura Poliseno, Ivana Barravecchia, Salvatore Gurrieri, Simone Lubrano, Debora Angeloni, Monica Evangelista, Elisa Mercoledi, Giovanna Chiorino, Alberto Mercatanti, Michael F. Gowen, Samanta Sarti, Laura Giannecchini, Marianna Vitiello, Alessandra Salvetti, Lawrence W. Wu, Marc R. Hammond, Keith T. Flaherty, Silvia Peppicelli, Genevieve M. Boland, Lawrence N. Kwong, Valentina Montagnani, Lido Calorini, Barbara Stecca, Iman Osman, Romina D'Aurizio, Andrea Marranci, Elena Guzzolino, Letizia Pitto, Mario Chiariello, Meenhard Herlyn
Publikováno v:
Oncotarget
// Marianna Vitiello 1, 2 , Andrea Tuccoli 1 , Romina D’Aurizio 3 , Samanta Sarti 1, 4 , Laura Giannecchini 1 , Simone Lubrano 1, 4 , Andrea Marranci 1, 4 , Monica Evangelista 2 , Silvia Peppicelli 5 , Chiara Ippolito 6 , Ivana Barravecchia 7 , Ele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9919ee57bb6981b31222d8fb7cbae46
http://hdl.handle.net/11568/852795
http://hdl.handle.net/11568/852795
Autor:
Michael F. Gowen, Sarah W. Ogburn, Takeshi Suzuki, Bill J. Yates, Lucy A Cotter, Yoichiro Sugiyama
Publikováno v:
Experimental Brain Research. 220:121-133
Stimulation of vestibular receptors elicits distinct changes in blood flow to the forelimb and hindlimb, showing that the nervous system has the capacity to produce changes in sympathetic outflow which are specific for a particular region of the body
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23454b13e00905cf727f6ec554569219
https://doi.org/10.1007/s00221-012-3122-8
https://doi.org/10.1007/s00221-012-3122-8
Autor:
Jeremy Tchack, Michael F. Gowen, Iman Osman, Hua Zhou, Michelle Krogsgaard, Melissa Wilson, Anna C. Pavlick, Robert Ferguson, Jeffrey S. Weber, Tomas Kirchhoff, Keith M. Giles, Zarmeena Dawood, Una Moran, Shaohui Hu, Danny Simpson, Hua Zhong
Publikováno v:
Annals of Oncology. 29:viii421
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa1882fcd621eb1f2d8aeb541c5b4610
https://doi.org/10.1093/annonc/mdy288.055
https://doi.org/10.1093/annonc/mdy288.055
Autor:
Michael E. Pacold, Jeremy Tchack, Michelle Krogsgaard, David Fenyö, Keith M. Giles, Michael F. Gowen, Hua Zhou, Iman Osman, Anna C. Pavlick, Aristotelis Tsirigos, Scott Paschke, Una Moran
Publikováno v:
Journal of Clinical Oncology. 35:9559-9559
9559 Background: There are no predictive biomarkers of ipilimumab (IPI) toxicity. Of metastatic melanoma (MM) patients (pts) receiving IPI (3mg/kg), 35% require systemic therapies to treat immune-related adverse events (irAEs) and 20% must terminate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed7105cdbcacde682aed02795169e924
https://doi.org/10.1200/jco.2017.35.15_suppl.9559
https://doi.org/10.1200/jco.2017.35.15_suppl.9559
Publikováno v:
The FASEB Journal. 26
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c78490886f10b40b8a7979bb76045dc5
https://doi.org/10.1096/fasebj.26.1_supplement.1091.2
https://doi.org/10.1096/fasebj.26.1_supplement.1091.2
Publikováno v:
The FASEB Journal. 26
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2425bf646eb179994365cb2f23e2d76e
https://doi.org/10.1096/fasebj.26.1_supplement.1091.14
https://doi.org/10.1096/fasebj.26.1_supplement.1091.14